Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Leber Congenital Amaurosis and Retinitis Pigmentosa via the CRB1 Gene PreventionGenetics United States | 2 | 1 |
|
VECMD Retina and Genomics Institute VECMD Mexico | 9 | 8 |
|
Macular dystrophy panel. NGS panel of 26 genes. Genologica Medica Spain | 50 | 26 |
|
Leber's congenital amaurosis panel. NGS panel of 26 genes. Genologica Medica Spain | 40 | 26 |
|
Rod and cone dystrophy panel. 42-gene NGS panel. Genologica Medica Spain | 65 | 41 |
|
Genologica Medica Spain | 164 | 108 |
|
Retinal dystrophy panel. 260 gene NGS panel. Genologica Medica Spain | 420 | 257 |
|
CRB1 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 1 | 1 |
|
Asper Biogene Asper Biogene LLC Estonia | 166 | 120 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 3 | 1 |
|
Retinitis pigmentosa: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 75 | 71 |
|
Retinopathy and Optic Atrophy NGS Panel Fulgent Genetics United States | 563 | 241 |
|
Beacon Expanded Female Carrier Screening Plus Panel Fulgent Genetics United States | 716 | 335 |
|
Beacon Expanded Male Carrier Screening Panel Fulgent Genetics United States | 636 | 298 |
|
Beacon Expanded Male Carrier Screening Plus Panel Fulgent Genetics United States | 661 | 306 |
|
Beacon Expanded Female Carrier Screening Panel Fulgent Genetics United States | 690 | 326 |
|
Retinitis Pigmentosa (Complet Panel) , Panel Massive Sequencing (NGS) 57 Genes Reference Laboratory Genetics Spain | 57 | 57 |
|
Autosomal Recessive and Sporadic Retinitis Pigmentosa, Panel Massive Sequencing (NGS) 41 Genes Reference Laboratory Genetics Spain | 41 | 41 |
|
Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 45 | 37 |
|
RETINITIS PIGMENTOSA (AUTOSOMAL RECESSIVE) Laboratorio de Genetica Clinica SL Spain | 10 | 10 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.